A clear look at what cancer DNA in blood can reveal, and what one tube can miss.
Blood sits at the centre of this episode as both a revealing signal and a limited sample. Kat Arney's conversation with Susan Galbraith, Executive Vice President for Oncology R&D at AstraZeneca, follows circulating tumour DNA through the appeal of liquid biopsies: detecting…






